Wyeth Librel NDA Accepted By FDA

Wyeth expects a standard 10-month review for its continuous-use contraceptive; the NDA for the low-dose levonorgestrel/ethinyl estradiol product was submitted May 27

More from Archive

More from Pink Sheet